Welcome to LookChem.com Sign In|Join Free

CAS

  • or

13671-00-6

Post Buying Request

13671-00-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

13671-00-6 Usage

Uses

Methyl 2,6-difluorobenzoate may be used in the synthesis of 9-hydroxy-13-(2,6-difluorophenyl)-3H-dibenzo[b,i]xanthen-3-one and 2,6-difluorobenzohydroxamic acid.

General Description

Methyl 2,6-difluorobenzoate is a fluorinated aromatic ester. It can be synthesized from 2,6-difluorobenzoic acid via esterification with methanol.

Check Digit Verification of cas no

The CAS Registry Mumber 13671-00-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,6,7 and 1 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 13671-00:
(7*1)+(6*3)+(5*6)+(4*7)+(3*1)+(2*0)+(1*0)=86
86 % 10 = 6
So 13671-00-6 is a valid CAS Registry Number.

13671-00-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (L08063)  Methyl 2,6-difluorobenzoate, 97%   

  • 13671-00-6

  • 5g

  • 342.0CNY

  • Detail
  • Alfa Aesar

  • (L08063)  Methyl 2,6-difluorobenzoate, 97%   

  • 13671-00-6

  • 25g

  • 1002.0CNY

  • Detail

13671-00-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name METHYL 2,6-DIFLUOROBENZOATE

1.2 Other means of identification

Product number -
Other names Methyl 2,6-difluorobenzoate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:13671-00-6 SDS

13671-00-6Relevant articles and documents

The importance of the ortho effect in the solvolyses of 2,6-difluorobenzoyl chloride

Park, Kyoung-Ho,Kevill, Dennis N.

, p. 267 - 270 (2012)

The ortho effect of the chloro substituents in 2,6-dichlorobenzoyl chloride sufficiently hindered attack on the acyl carbon such that an ionization mechanism was observed over the full range of solvents studied. We now compare this behavior with that of 2,6-difluorobenzoyl chloride. The smaller fluoro substituents allow the dominant pathway to be addition-elimination (association-dissociation) in all solvents except those rich in fluoroalcohol, where ionization is dominant. Ranges of operation for both mechanisms had previously been observed for the parent benzoyl chloride but with a wider ionization range than for the 2,6-difluoro derivative. This indicates that, relative to the parent, the electronic destabilizing influence of the fluorines on acyl cation formation outweighs the steric retardation to attack because of the presence of the two ortho-fluorine atoms. An extended (two-term) Grunwald-Winstein equation treatment of the solvolyses of 2,6-difluorobenzoyl chloride is reported. Copyright

Nickel-Catalyzed Esterification of Amides Under Mild Conditions

Li, Jun-Fei,Wang, Yao-Fang,Wu, Yuan-Yuan,Liu, Wen-Jing,Wang, Jun-Wen

, p. 874 - 880 (2019/11/13)

Abstract: The use of ligands to adjust the catalytic activity of the catalyst for esterification of amides is challenge in organic chemistry. In this paper, Nickel(II)-NHC-catalyzed the esterification reaction between N,N-di-Boc amide and alcohols at room temperature have been demonstrated. The imidazolium salt bearing a hydroxyl functionalized side arm showed high effective catalytic activity in the activation of the amide N–C bond in air atmosphere. Graphic Abstract: [Figure not available: see fulltext.].

Protein kinase inhibitor and its composition and use thereof

-

Paragraph 0147-0149, (2017/08/02)

The invention relates to compounds as shown in the general formula (I), pharmaceutical compositions containing the compounds, a method for treating diseases and disease symptoms related to abnormal activity of protein kinase by using the compounds, and medicinal use of the compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 13671-00-6